Fatty Pancreas on CT Scans Linked to Age, Body Fat and Duct Changes in New Study

The pancreas, the quiet workhorse of digestion and blood sugar control, has long lived in the shadow of its more famous neighbor, the liver, when it comes to fat accumulation. Fatty liver disease has become a household phrase, but fatty pancreas disorder, the accumulation of fat inside pancreatic tissue, remains poorly understood, partly because clinicians have lacked a reliable, standardized way to spot it on routine imaging. Now a team of radiologists and gastroenterologists at the University Hospital of Saint-Etienne in France has taken a significant step toward changing that, showing that a fatty pancreas leaves a recognizable fingerprint on ordinary computed tomography scans, one that combines age, body composition, organ shape and even the width of the pancreatic duct.

The study, published in BMC Medical Imaging, set out to answer a deceptively simple question: which clinical and radiological factors are independently associated with fatty pancreas disorder on CT? The researchers retrospectively analyzed 389 adult patients who underwent endoscopic retrograde cholangiopancreatography, or ERCP, between September 2014 and June 2023 and who had undergone a prior CT scan. Because every patient already had both a CT and an ERCP on record, the dataset offered an unusually rich window into pancreatic anatomy and physiology, allowing the team to measure not only fat inside the gland itself but also the surrounding landscape of visceral fat, subcutaneous fat, skeletal muscle and muscle density.

The technical backbone of the study is the Hounsfield unit, the standardized density scale of CT imaging. Fat reads as dark, or low attenuation, on CT, while healthy soft tissue reads brighter. The researchers defined fatty pancreas disorder as unenhanced pancreatic attenuation of 15 Hounsfield units or less, a cutoff approximating the lowest quartile of the attenuation distribution in their cohort. In plain terms, a pancreas that darkens to this degree on a scan contains enough fat to stand apart from the majority of glands. Using this definition, fatty pancreas disorder was present in 106 of the 389 patients, or 27.2 percent, a strikingly high proportion that underscores how common the condition may be in populations undergoing pancreatic evaluation.

What makes the study more than a simple prevalence count is the multivariable analysis the team performed. Rather than looking at each factor in isolation, they used logistic regression to determine which variables remained independently associated with a fatty pancreas after accounting for the others. Four predictors survived this statistical gauntlet. Older age carried an odds ratio of 1.06 per year, meaning each additional year of life modestly increased the odds of a fatty gland. The absence of a smooth pancreatic contour, meaning an irregular or lobulated gland outline, was associated with fatty pancreas disorder. A smaller main pancreatic duct diameter also predicted the condition, with an odds ratio of 0.65 per unit increase in duct size, and lower mesenteric fat attenuation, a marker of fat quality in the abdominal cavity, rounded out the picture with an odds ratio of 0.96.

Some of the raw group comparisons are equally telling. Patients with fatty pancreas disorder were significantly older than those without it, averaging 81.1 years against 71.5 years, a difference that was highly statistically significant. They also carried more visceral fat, the metabolically active fat wrapped around internal organs, with a mean visceral fat area of 242.1 square centimeters compared with 200.2 square centimeters in patients whose pancreas remained lean. Visceral fat area is measured directly on CT by tracing the fat compartment inside the abdominal cavity, and it is widely regarded as a more meaningful marker of metabolic risk than body mass index, which cannot distinguish muscle from fat or subcutaneous from visceral deposits.

The correlation analysis adds a layer of physiological coherence to the findings. Pancreatic attenuation, treated as a continuous variable, showed a negative correlation with age, with a correlation coefficient of minus 0.34, and a negative correlation with visceral fat area at minus 0.25. In other words, the older the patient and the larger the visceral fat store, the darker and fattier the pancreas appeared. Conversely, pancreatic attenuation correlated positively with psoas skeletal muscle density at plus 0.26 and with main pancreatic duct diameter at plus 0.26. Dense, healthy muscle and a wider duct traveled together with a leaner gland, painting a picture of fatty pancreas as part of a broader systemic phenotype rather than an isolated organ quirk.

That systemic dimension is where the mesenteric fat finding becomes intriguing. Mesenteric fat attenuation reflects not just how much fat surrounds the intestines but what kind of fat it is; lower attenuation suggests fat that is denser on the CT scale, which in this context the researchers found associated with a fatty pancreas. The idea that the quality of fat elsewhere in the abdomen mirrors the fat content of the pancreas hints at shared metabolic pathways, possibly involving inflammation, insulin resistance and ectopic lipid storage, the process by which fat spills into organs never designed to hold it. The same logic underlies the study’s interest in skeletal muscle density, since fatty infiltration of muscle, known as myosteatosis, is another recognized marker of metabolic dysfunction.

A crucial strength of the work lies in its sensitivity analyses, which tested whether the findings depended on the arbitrary choice of a single attenuation cutoff. The researchers re-ran their models using a pancreas-to-spleen attenuation ratio, an alternative absolute threshold of 30 Hounsfield units or less, and pancreatic attenuation modeled as a continuous variable. The association with irregular pancreatic contour proved robust across all these alternative definitions, suggesting it is a genuine morphological companion of pancreatic steatosis. The link with main pancreatic duct diameter, by contrast, was definition-dependent, meaning it appeared under some definitions but not others, a nuance the authors transparently report and one that future studies will need to resolve.

Reproducibility received attention as well. In a random subsample of 50 patients, the team assessed how consistently different observers classified the pancreatic contour, an essential quality check for any imaging feature proposed as a biomarker. If two radiologists cannot agree on whether a contour is smooth or irregular, the feature is of little clinical use, and the reproducibility testing in this study addresses that concern directly. The broader context also matters: the study was conducted in accordance with the Declaration of Helsinki, approved by the institutional review board of CHU de Saint-Etienne, and carried out without external funding, with the authors declaring no competing interests.

Why should ordinary readers care about a dark pancreas on a CT scan? The pancreas performs two jobs essential to life: it secretes digestive enzymes into the gut and it releases insulin and glucagon into the bloodstream to regulate blood sugar. Fat crowding pancreatic tissue has been linked in other research to impaired insulin secretion and elevated risk of type 2 diabetes, and it may interact with pancreatic inflammation and even cancer risk, though this study was designed to identify imaging associations rather than outcomes. What the Saint-Etienne team has delivered is a practical observation: fatty pancreas disorder travels with a distinct metabolic and morphological phenotype, one that a radiologist can begin to recognize on scans already being performed for other reasons. As CT scanners continue to generate vast archives of abdominal images, findings like these suggest that the pancreas, long a silent bystander in the obesity epidemic, may be quietly recording the same story of aging and visceral fat that the liver has been telling all along, and that the tools to read that story are already in every hospital.

Subject of Research: Radiological and clinical predictors of fatty pancreas disorder on computed tomography

Article Title: Fatty pancreas disorder on CT: associations with mesenteric fat attenuation, irregular contour, and reduced main pancreatic duct diameter

Article References: Fatty pancreas disorder on CT: associations with mesenteric fat attenuation, irregular contour, and reduced main pancreatic duct diameter. (n.d.). https://doi.org/10.1186/s12880-026-02925-9

Image Credits: AI Generated

DOI: 10.1186/s12880-026-02925-9

Keywords: fatty pancreas disorder, computed tomography, pancreatic steatosis, visceral fat, mesenteric fat attenuation, main pancreatic duct, Hounsfield units, body composition, myosteatosis, ERCP, pancreatic contour, metabolic dysfunction